Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Zaimer reported for 9 months of 2024 by IFRS

10/24/24 ZAYM

X5 Group reported for 9 months of 2024 by IFRS

10/24/24 FIVE

MMK reported for 9 months of 2024 by IFRS

10/24/24 MAGN

Segezha Group intends to enter the South Korean market

10/24/24 SGZH

Samolet reported for 9 months of 2024 by RAS

10/24/24 SMLT

RusHydro's generation in 9 months increased by 3.3%

10/24/24 HYDR

Investment company Fundament Capital acquired 6.9% of Moscow Exchange

10/23/24 MOEX

UWC reported for 6 months of 2024 by RAS

10/23/24 UWGN

State may sell part of VTB shares

10/23/24 VTBR

Moscow Exchange will create an expert council to select companies for pre-IPOs

10/23/24 MOEX